Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines

Azusa Sugiyama, Akiyoshi Saitoh, Takashi Iwai, Kou Takahashi, Misa Yamada, Sachie Sasaki-Hamada, Jun Ichiro Oka, Masatoshi Inagaki, Mitsuhiko Yamada

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In this study, we investigated the anxiolytic-like effect of riluzole using three different innate anxiety models in rats. In the elevated plus-maze test, riluzole significantly increased the time spent in, and entries into, the open arm after 60 min administration. This finding was supported by results obtained from light/dark and open-field tests. The magnitude of the anxiolytic-like effects of riluzole in each of the behavioral models was similar to those produced by a benzodiazepine, diazepam, suggesting that riluzole has a robust anxiolytic-like activity in rats. To clarify the involvement of sodium channels in this anxiolytic activity, we examined the effect of a co-administered sodium channel activator, veratrine. The anxiolytic-like action of riluzole was diminished by veratrine in the elevated plus-maze, light/dark and open-field tests. Based on these results, it is suggested that the anxiolytic mechanism of riluzole is clearly distinct from that of diazepam. In addition, to examine whether riluzole directly and non-selectively affected the GABA A-benzodiazepine receptor complex, we performed three behavioral tests (footprint analysis, Y-maze test and the ethanol-induced sleeping time test) that are closely related to the GABA A-benzodiazepine pathways. In contrast to diazepam, riluzole produced no significant effects in these tests. Here, we provide the first report demonstrating that riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Crown

Original languageEnglish
Pages (from-to)2489-2498
Number of pages10
JournalNeuropharmacology
Volume62
Issue number8
DOIs
Publication statusPublished - Jun 2012
Externally publishedYes

Fingerprint

Riluzole
Anti-Anxiety Agents
Benzodiazepines
Veratrine
Diazepam
GABA-A Receptors
Sodium Channel Agonists
Light
Sodium Channels
Crowns
gamma-Aminobutyric Acid
Ethanol
Anxiety

Keywords

  • Behavioral
  • Elevated plus-maze
  • GABA
  • Glutamate
  • Veratrine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Sugiyama, A., Saitoh, A., Iwai, T., Takahashi, K., Yamada, M., Sasaki-Hamada, S., ... Yamada, M. (2012). Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Neuropharmacology, 62(8), 2489-2498. https://doi.org/10.1016/j.neuropharm.2012.02.012

Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. / Sugiyama, Azusa; Saitoh, Akiyoshi; Iwai, Takashi; Takahashi, Kou; Yamada, Misa; Sasaki-Hamada, Sachie; Oka, Jun Ichiro; Inagaki, Masatoshi; Yamada, Mitsuhiko.

In: Neuropharmacology, Vol. 62, No. 8, 06.2012, p. 2489-2498.

Research output: Contribution to journalArticle

Sugiyama, A, Saitoh, A, Iwai, T, Takahashi, K, Yamada, M, Sasaki-Hamada, S, Oka, JI, Inagaki, M & Yamada, M 2012, 'Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines', Neuropharmacology, vol. 62, no. 8, pp. 2489-2498. https://doi.org/10.1016/j.neuropharm.2012.02.012
Sugiyama, Azusa ; Saitoh, Akiyoshi ; Iwai, Takashi ; Takahashi, Kou ; Yamada, Misa ; Sasaki-Hamada, Sachie ; Oka, Jun Ichiro ; Inagaki, Masatoshi ; Yamada, Mitsuhiko. / Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. In: Neuropharmacology. 2012 ; Vol. 62, No. 8. pp. 2489-2498.
@article{58645b034bbb4f2cae01ee8fdada729a,
title = "Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines",
abstract = "In this study, we investigated the anxiolytic-like effect of riluzole using three different innate anxiety models in rats. In the elevated plus-maze test, riluzole significantly increased the time spent in, and entries into, the open arm after 60 min administration. This finding was supported by results obtained from light/dark and open-field tests. The magnitude of the anxiolytic-like effects of riluzole in each of the behavioral models was similar to those produced by a benzodiazepine, diazepam, suggesting that riluzole has a robust anxiolytic-like activity in rats. To clarify the involvement of sodium channels in this anxiolytic activity, we examined the effect of a co-administered sodium channel activator, veratrine. The anxiolytic-like action of riluzole was diminished by veratrine in the elevated plus-maze, light/dark and open-field tests. Based on these results, it is suggested that the anxiolytic mechanism of riluzole is clearly distinct from that of diazepam. In addition, to examine whether riluzole directly and non-selectively affected the GABA A-benzodiazepine receptor complex, we performed three behavioral tests (footprint analysis, Y-maze test and the ethanol-induced sleeping time test) that are closely related to the GABA A-benzodiazepine pathways. In contrast to diazepam, riluzole produced no significant effects in these tests. Here, we provide the first report demonstrating that riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Crown",
keywords = "Behavioral, Elevated plus-maze, GABA, Glutamate, Veratrine",
author = "Azusa Sugiyama and Akiyoshi Saitoh and Takashi Iwai and Kou Takahashi and Misa Yamada and Sachie Sasaki-Hamada and Oka, {Jun Ichiro} and Masatoshi Inagaki and Mitsuhiko Yamada",
year = "2012",
month = "6",
doi = "10.1016/j.neuropharm.2012.02.012",
language = "English",
volume = "62",
pages = "2489--2498",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines

AU - Sugiyama, Azusa

AU - Saitoh, Akiyoshi

AU - Iwai, Takashi

AU - Takahashi, Kou

AU - Yamada, Misa

AU - Sasaki-Hamada, Sachie

AU - Oka, Jun Ichiro

AU - Inagaki, Masatoshi

AU - Yamada, Mitsuhiko

PY - 2012/6

Y1 - 2012/6

N2 - In this study, we investigated the anxiolytic-like effect of riluzole using three different innate anxiety models in rats. In the elevated plus-maze test, riluzole significantly increased the time spent in, and entries into, the open arm after 60 min administration. This finding was supported by results obtained from light/dark and open-field tests. The magnitude of the anxiolytic-like effects of riluzole in each of the behavioral models was similar to those produced by a benzodiazepine, diazepam, suggesting that riluzole has a robust anxiolytic-like activity in rats. To clarify the involvement of sodium channels in this anxiolytic activity, we examined the effect of a co-administered sodium channel activator, veratrine. The anxiolytic-like action of riluzole was diminished by veratrine in the elevated plus-maze, light/dark and open-field tests. Based on these results, it is suggested that the anxiolytic mechanism of riluzole is clearly distinct from that of diazepam. In addition, to examine whether riluzole directly and non-selectively affected the GABA A-benzodiazepine receptor complex, we performed three behavioral tests (footprint analysis, Y-maze test and the ethanol-induced sleeping time test) that are closely related to the GABA A-benzodiazepine pathways. In contrast to diazepam, riluzole produced no significant effects in these tests. Here, we provide the first report demonstrating that riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Crown

AB - In this study, we investigated the anxiolytic-like effect of riluzole using three different innate anxiety models in rats. In the elevated plus-maze test, riluzole significantly increased the time spent in, and entries into, the open arm after 60 min administration. This finding was supported by results obtained from light/dark and open-field tests. The magnitude of the anxiolytic-like effects of riluzole in each of the behavioral models was similar to those produced by a benzodiazepine, diazepam, suggesting that riluzole has a robust anxiolytic-like activity in rats. To clarify the involvement of sodium channels in this anxiolytic activity, we examined the effect of a co-administered sodium channel activator, veratrine. The anxiolytic-like action of riluzole was diminished by veratrine in the elevated plus-maze, light/dark and open-field tests. Based on these results, it is suggested that the anxiolytic mechanism of riluzole is clearly distinct from that of diazepam. In addition, to examine whether riluzole directly and non-selectively affected the GABA A-benzodiazepine receptor complex, we performed three behavioral tests (footprint analysis, Y-maze test and the ethanol-induced sleeping time test) that are closely related to the GABA A-benzodiazepine pathways. In contrast to diazepam, riluzole produced no significant effects in these tests. Here, we provide the first report demonstrating that riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Crown

KW - Behavioral

KW - Elevated plus-maze

KW - GABA

KW - Glutamate

KW - Veratrine

UR - http://www.scopus.com/inward/record.url?scp=84859711158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859711158&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2012.02.012

DO - 10.1016/j.neuropharm.2012.02.012

M3 - Article

VL - 62

SP - 2489

EP - 2498

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 8

ER -